MAPK1 and major depressive disorder: To predict the potential interaction effects of HP on these five key targets in MDD, we used three major active ingredients of HP, including quercetin, kaempferol, and luteolin, to dock with MAPK1, EGF, HSP90AA1, AKT1, and MYC, respectively (Fig. 10A, B).